Here are three things you need to know in the financial markets this morning from investment writer, Tony Cross.
#1. Nightcap signs lease on a new property in the City of London
It’s another quiet day in terms of pre-market regulatory filings but we do have an announcement from Nightcap [LON:NGHT], the AIM listed bar operator, that it has signed a lease on a new property in the City of London. It expects to open the venue before the year end, offering some insight from the firm as to how it thinks the market will continue growing into the Winter. The note adds that negotiations are currently ongoing over a further five sites.
#2. Belluscura expects pandemic to increase demand for oxygen therapies
Sticking with AIM, Belluscura [LON:BELL], the manufacturer of portable oxygen generators whose shares debuted back in May, has published its half year report this morning. The company believes that the long term health impacts of the COVID-19 pandemic will increase demand for oxygen therapies and accelerate market growth. Distribution of its first units only started last week, so the balance sheet is still very much pre-revenue but this could be a firm that is very much responding to the needs of the day.
#3. Vela Technologies pushes back trial results
Finally, a quick update from Vela Technologies [LON:VELA] over trials being conducted for diabetic patients suffering from COVID-19. It had previously expected to report results here by today, but the note advises that these findings have been pushed back to no later than Friday September 10th.